It applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large, the agency report said, citing official sources. The Serum Institute was not immediately available to Reuters request for comment.

Source: bd News24 December 07, 2020 02:03 UTC